209 related articles for article (PubMed ID: 34453927)
1. Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder.
Brunaugh AD; Ding L; Wu T; Schneider M; Khalaf R; Smyth HDC
J Pharm Sci; 2022 Feb; 111(2):403-416. PubMed ID: 34453927
[TBL] [Abstract][Full Text] [Related]
2. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
[TBL] [Abstract][Full Text] [Related]
3. Spray-Dried and Spray-Freeze-Dried Powder Formulations of an Anti-Interleukin-4Rα Antibody for Pulmonary Delivery.
Pan HW; Seow HC; Lo JCK; Guo J; Zhu L; Leung SWS; Zhang C; Lam JKW
Pharm Res; 2022 Sep; 39(9):2291-2304. PubMed ID: 35879500
[TBL] [Abstract][Full Text] [Related]
4. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
5. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.
Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z
Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system.
Yu YS; Xu H; AboulFotouh K; Williams G; Suman J; Sahakijpijarn S; Cano C; Warnken ZN; Wu KC; Williams RO; Cui Z
Int J Pharm; 2024 Mar; 653():123892. PubMed ID: 38350499
[TBL] [Abstract][Full Text] [Related]
7. Protein inhalation powders: spray drying vs spray freeze drying.
Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
[TBL] [Abstract][Full Text] [Related]
8. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray drying: Models and pitfalls.
Batens M; Massant J; Teodorescu B; Van den Mooter G
Eur J Pharm Biopharm; 2018 Jun; 127():407-422. PubMed ID: 29499299
[TBL] [Abstract][Full Text] [Related]
9. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
[TBL] [Abstract][Full Text] [Related]
10. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
Tanaka R; Hattori Y; Otsuka M; Ashizawa K
Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
[TBL] [Abstract][Full Text] [Related]
11. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders.
Maa YF; Nguyen PA; Andya JD; Dasovich N; Sweeney TD; Shire SJ; Hsu CC
Pharm Res; 1998 May; 15(5):768-75. PubMed ID: 9619788
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
13. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
Saboti D; Maver U; Chan HK; Planinšek O
J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
[TBL] [Abstract][Full Text] [Related]
14. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
[TBL] [Abstract][Full Text] [Related]
15. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
[TBL] [Abstract][Full Text] [Related]
16. Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation.
Chen Y; Yan S; Zhang S; Yin Q; Chen XD; Wu WD
AAPS PharmSciTech; 2022 Aug; 23(6):211. PubMed ID: 35915199
[TBL] [Abstract][Full Text] [Related]
17. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM
Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627
[TBL] [Abstract][Full Text] [Related]
18. Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.
D'Addio SM; Chan JG; Kwok PC; Benson BR; Prud'homme RK; Chan HK
Pharm Res; 2013 Nov; 30(11):2891-901. PubMed ID: 23893019
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
Wang J; Kutter JP; Mu H; Moodley A; Yang M
Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
[TBL] [Abstract][Full Text] [Related]
20. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
